Takeda has launched three new diabetes treatments: Nesina (alogliptin), Kazano (alogliptin and metformin HCl), and Oseni (alogliptin and pioglitazone).
For patients with early rheumatoid arthritis, being overweight or obese is associated with an increased likelihood of not achieving remission.
For patients with rheumatoid arthritis, the median time to discontinuation of therapy is 25.1 months, with longer time to discontinuation noted for those receiving tumor necrosis factor inhibitors.
In overweight or obese women, missing breakfast is associated with insulin resistance.
There are considerable racial and ethnic differences in the use of specialty care and procedures among children diagnosed with autism.
Gains in neonatal weight and head circumference in the first four weeks of life correlate with children's IQ at early school-age.
Sibling aggression has a detrimental effect on children's and adolescents' mental health.
Initiating statin therapy is associated with an increased risk of type 2 diabetes, which is not explained by differential survival.
Neurological testing procedures have limited diagnostic accuracy for detecting disc herniation with suspected radiculopathy.
Amedra announced the relaunch of Adrenaclick (epinephrine) auto-injector for the emergency treatment of anaphylaxis.